First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
This is a first time in-human (FTIH) study designed to investigate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of GSK4381562 in participants with select loco-regionally recurrent solid tumors or metastatic solid tumors where curative or standard treatment options have been exhausted
创建时间：
2022-03-15
